Apply on Employer Site

Kite Pharma · 2 days ago

Director, Value Access & Strategy

Santa Monica, CA

Full-time

Onsite

Director/Executive

$206K/yr - $266K/yr

10+ years exp

Kite Pharma is a biopharmaceutical company dedicated to curing cancer through innovative therapies. The Director of Value Access & Strategy will be responsible for developing global market access strategies for key CAR T launches and collaborating with various teams to ensure seamless execution of access strategies and reimbursement plans.

BiotechnologyHealth CareMedicalOncologyTherapeutics

Comp. & Benefits

Responsibilities

Execute the 4L+ iMMagine-1 Global Launch, where you will be developing the global market access strategy to support the ex-US launch together with the key commercialization functions of Marketing, Medical Affairs, and Technical Operations and regional Access team

Prepare the 2L+ iMMagine-3 Global Launch, where you will partner with regional (US, ACE, ICR) teams to optimize the access and reimbursement strategies for anito-cel in 2L RR-MM. Working closely with HEOR/RWE to ensure the production of compelling Payer Value Evidence tools to ensure rapid access

Key Market Access representative and lead in the Global Brand Team and Join-GBT for anito-cel

In the Value Access Sub-Team, you will be partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure seamless execution of the Access Strategy

Analyze future market access trends and competitor entry and advise the GBT/PT on access-relevant endpoints, study designs, and magnitude of effect to be targeted to achieve reimbursement. The focus will be on Kite’s major markets of US, Australia, Canada, EU-5 (ACE-7), and Japan. You will inform development plans to ensure that Kite pursues evidence generation plans that are meeting payer needs and ultimately, Kite’s commercial ambitions

Provide input into clinical development programs to capture value, align to what is meaningful to patients, support a differentiated target product profile (TPP), and ensure the right evidence is collected to support future reimbursement and pricing negotiations

Accountable for the market access and payer perspective to be reflected in cross functional strategies (product development, medical affairs, regulatory affairs, commercial)

Partner with Health Economics Outcomes Research (HEOR), Real-World Evidence (RWE), and Global Marketing to ensure meaningful target product profiles are developed and evidence plans are optimized to support reimbursement

Identify global HEOR evidence requirements and gaps; coordinate with HEOR to develop studies, models, and resources to support value demonstration and product differentiation for assigned indication(s)

Qualification

Market Access StrategyOncology Product LaunchesHEOR/RWE CollaborationPayer Value EvidenceGlobal Market Access LandscapePricingReimbursementHTA AssessmentsLeadership SkillsCommunication SkillsCollaboration Skills

Required

12+ Years with BS/BA OR

10+ Years with MS/MA or MBA

Preferred

Previous experience supporting product launches, ideally in oncology

Demonstrated experience in healthcare environment, preferably pharmaceutical industry, or related consulting services

Extensive understanding of the global hematology / multiple myeloma market access landscape, the business of cell therapy, and healthcare system dynamics

Detailed knowledge of payer systems, pricing and reimbursement mechanisms, decision-makers, and payer stakeholder behavior for relevant markets (US, EU5, Japan)

Knowledge of HTA assessments including value frameworks utilized, methodologies, trends, and drivers in relevant markets

Ability to guide the development plan and lead inputs based on payer requirements / market access trends

Excellent communication skills and experience in presenting at senior committees

Ability to collaborate successfully and cooperatively with colleagues across multiple cultures and time-zones

Demonstrated leadership in cross-functional teams